Assessing the validity and reliability of the Arabic versions of Mini Asthma Quality of life questionnaire and Asthma Control Test in adult patients with asthma: A factor analysis study.

ACT CFA EFA Mini AQLQ

Journal

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
ISSN: 1319-0164
Titre abrégé: Saudi Pharm J
Pays: Saudi Arabia
ID NLM: 9705695

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 11 06 2023
accepted: 15 11 2023
medline: 9 1 2024
pubmed: 9 1 2024
entrez: 9 1 2024
Statut: ppublish

Résumé

Asthma is a common disease that has a significant influence on patients' quality of life. Although Arabic tools for assessing symptom control and quality of life in individuals with asthma are available, no sufficient studies have evaluated the validity of these tools. Therefore, the aim of the current study was to validate the Arabic version of these tools. Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) were conducted on the Arabic versions of the Asthma Control Test (ACT) and Mini Asthma Quality of Life Questionnaire (Mini AQLQ). A total of 314 participants (70.1 % females) were enrolled in the current study. The mean age of the participants was 51.47 (±16.37). EFA suggested a three-factor model for Mini AQLQ and a one-factor model for ACT, which was confirmed by CFA analyses. High correlations were found between spirometric values and ACT and Mini AQLQ scores, indicating good concurrent validity. The area under the curve produced by the Roc curve was 0.861 (p < 0.001), and the most suitable cut-off point was 4.741. All analyses conducted showed that the Arabic versions of both Mini AQLQ and ACT are reliable and valid and can be administered to adults with asthma. The application of these validated instruments will improve the management and diagnosis of asthma in Arab countries.

Sections du résumé

Background and objective UNASSIGNED
Asthma is a common disease that has a significant influence on patients' quality of life. Although Arabic tools for assessing symptom control and quality of life in individuals with asthma are available, no sufficient studies have evaluated the validity of these tools. Therefore, the aim of the current study was to validate the Arabic version of these tools.
Methods UNASSIGNED
Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) were conducted on the Arabic versions of the Asthma Control Test (ACT) and Mini Asthma Quality of Life Questionnaire (Mini AQLQ).
Results UNASSIGNED
A total of 314 participants (70.1 % females) were enrolled in the current study. The mean age of the participants was 51.47 (±16.37). EFA suggested a three-factor model for Mini AQLQ and a one-factor model for ACT, which was confirmed by CFA analyses. High correlations were found between spirometric values and ACT and Mini AQLQ scores, indicating good concurrent validity. The area under the curve produced by the Roc curve was 0.861 (p < 0.001), and the most suitable cut-off point was 4.741.
Conclusion UNASSIGNED
All analyses conducted showed that the Arabic versions of both Mini AQLQ and ACT are reliable and valid and can be administered to adults with asthma. The application of these validated instruments will improve the management and diagnosis of asthma in Arab countries.

Identifiants

pubmed: 38192282
doi: 10.1016/j.jsps.2023.101878
pii: S1319-0164(23)00373-0
pmc: PMC10772248
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101878

Informations de copyright

© 2023 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Walid Al-Qerem (W)

Department of Pharmacy, AlZaytoonah University of Jordan, Amman, Jordan.

Anan Jarab (A)

Collage of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
Department of Clinical Pharmacy, Faculty of Pharmacy, University of Science and Technology, Irbid, Jordan, Jordan.
AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.

Abdel Qader Al Bawab (AQA)

Department of Pharmacy, AlZaytoonah University of Jordan, Amman, Jordan.

Alaa Hammad (A)

Department of Pharmacy, AlZaytoonah University of Jordan, Amman, Jordan.

Jonathan Ling (J)

Faculty of Health Sciences and Wellbeing, University of Sunderland, Chester Road, Sunderland, United Kingdom.

Fawaz Alasmari (F)

Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Saudi, Riyadh.

Khaled Al Oweidat (KA)

Pulmonary and Sleep Department, The University of Jordan, Amman, Jordan.

Sarah Ibrahim (S)

Department of Clinical Pharmacy, The University of Jordan, Amman, Jordan.

Classifications MeSH